Outlook Therapeutics files for FDA approval of ONS-5010 for eye disorder
01 April 2022 - 12:14AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From Apr 2024 to May 2024
Outlook Therapeutics (NASDAQ:OTLK)
Historical Stock Chart
From May 2023 to May 2024